IT-ChemLtd (KOSDAQ:309710) Seems To Be Using A Lot Of Debt
Nov 14
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedNov 14, 2025
DataAggregated Company Financials
Companies369
- 7D6.6%
- 3M18.0%
- 1Y33.9%
- YTD33.1%
The Healthcare industry is up 5.1% in the last week, with Celltrion up 13%. During this same period, the PharmaResearch underperformed, falling 7.5%. In the last 12 months, the industry was up 33%. Earnings are forecast to grow by 35% annually.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 15 Nov 2025 | ₩349.9t | ₩60.4t | ₩2.1t | 20.2x | 163.3x | 5.8x |
| Mon, 13 Oct 2025 | ₩304.4t | ₩60.3t | ₩2.1t | 20.3x | 147.2x | 5x |
| Wed, 10 Sep 2025 | ₩303.0t | ₩60.0t | ₩1.9t | 21.6x | 156.8x | 5x |
| Fri, 08 Aug 2025 | ₩290.8t | ₩58.5t | ₩1.4t | 22.2x | 200.8x | 5x |
| Sun, 06 Jul 2025 | ₩280.9t | ₩57.9t | ₩1.5t | 20.8x | 187.3x | 4.8x |
| Tue, 03 Jun 2025 | ₩273.3t | ₩57.6t | ₩1.5t | 22x | 183.4x | 4.7x |
| Thu, 01 May 2025 | ₩266.7t | ₩56.1t | ₩1.4t | 18.7x | 195.6x | 4.8x |
| Sat, 29 Mar 2025 | ₩263.3t | ₩56.2t | ₩1.1t | 16.4x | 237.8x | 4.7x |
| Mon, 24 Feb 2025 | ₩283.1t | ₩54.7t | ₩897.3b | 15.3x | 315.5x | 5.2x |
| Wed, 22 Jan 2025 | ₩263.3t | ₩54.5t | ₩828.4b | 14.9x | 317.8x | 4.8x |
| Fri, 20 Dec 2024 | ₩253.3t | ₩54.4t | ₩806.4b | 13.6x | 314.1x | 4.7x |
| Sun, 17 Nov 2024 | ₩252.2t | ₩53.2t | ₩910.6b | 15.3x | 277x | 4.7x |
| Tue, 15 Oct 2024 | ₩278.5t | ₩53.3t | ₩854.8b | 16.2x | 325.8x | 5.2x |
| Thu, 12 Sep 2024 | ₩258.2t | ₩53.4t | ₩856.0b | 16.6x | 301.6x | 4.8x |
| Sat, 10 Aug 2024 | ₩259.5t | ₩52.3t | ₩756.6b | 16.3x | 343x | 5x |
| Mon, 08 Jul 2024 | ₩242.2t | ₩52.3t | ₩749.4b | 16.7x | 323.2x | 4.6x |
| Wed, 05 Jun 2024 | ₩228.1t | ₩53.0t | ₩716.3b | 16.7x | 318.5x | 4.3x |
| Fri, 03 May 2024 | ₩235.6t | ₩52.3t | ₩538.5b | 18.4x | 437.5x | 4.5x |
| Sun, 31 Mar 2024 | ₩246.0t | ₩52.3t | ₩487.3b | 18.1x | 504.8x | 4.7x |
| Tue, 27 Feb 2024 | ₩230.3t | ₩52.0t | -₩48,458,490,006.00 | 23.1x | -4752x | 4.4x |
| Thu, 25 Jan 2024 | ₩233.0t | ₩55.7t | ₩55.5b | 23.3x | 4201.5x | 4.2x |
| Sat, 23 Dec 2023 | ₩222.0t | ₩56.1t | ₩267.5b | 21.7x | 830x | 4x |
| Mon, 20 Nov 2023 | ₩207.8t | ₩55.8t | ₩409.0b | 20.1x | 508.2x | 3.7x |
| Wed, 18 Oct 2023 | ₩204.8t | ₩56.0t | ₩1.0t | 18.7x | 200.1x | 3.7x |
| Fri, 15 Sep 2023 | ₩217.7t | ₩56.0t | ₩933.2b | 20.3x | 233.3x | 3.9x |
| Sun, 13 Aug 2023 | ₩224.2t | ₩56.1t | ₩2.1t | 22.9x | 107.3x | 4x |
| Tue, 11 Jul 2023 | ₩196.4t | ₩56.1t | ₩2.1t | 19.8x | 93.3x | 3.5x |
| Thu, 08 Jun 2023 | ₩217.2t | ₩56.3t | ₩2.1t | 21x | 102.9x | 3.9x |
| Sat, 06 May 2023 | ₩216.9t | ₩58.4t | ₩3.2t | 21.6x | 66.7x | 3.7x |
| Mon, 03 Apr 2023 | ₩203.5t | ₩58.3t | ₩3.3t | 19.8x | 62.6x | 3.5x |
| Wed, 01 Mar 2023 | ₩199.8t | ₩57.8t | ₩4.6t | 18.9x | 43.4x | 3.5x |
| Fri, 27 Jan 2023 | ₩205.7t | ₩57.8t | ₩4.6t | 17x | 44.6x | 3.6x |
| Sun, 25 Dec 2022 | ₩206.8t | ₩57.5t | ₩3.9t | 16x | 53.1x | 3.6x |
| Tue, 22 Nov 2022 | ₩212.3t | ₩56.9t | ₩4.1t | 15.7x | 52x | 3.7x |
Price to Earnings Ratio
52x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 163x which is lower than its 3-year average PE of 272x.
- The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 19% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | 1.57% | |
| Healthcare | 6.61% | |
| Biotech | 11.60% | |
| Medical Equipment | 6.76% | |
| Pharma | 5.37% | |
| Healthcare Services | 4.13% | |
| Life Sciences | 1.64% | |
| Healthtech | -5.65% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 38.7%, which is higher than its past year's earnings decline of 3.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 67% over the next 5 years.
- This is better than its past earnings decline of 3.3% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 24% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A068270 Celltrion | ₩196.10k | 13.4% +₩5.1t | 29.5% | PE87.8x | |
| A298380 ABL Bio | ₩174.20k | 72.0% +₩4.0t | 435.2% | PS108.6x | |
| A196170 ALTEOGEN | ₩554.00k | 4.9% +₩1.4t | 26.6% | PE314.2x | |
| A141080 LigaChem Biosciences | ₩175.50k | 17.9% +₩972.2b | 46.3% | PE3648.2x | |
| A326030 SK Biopharmaceuticals | ₩128.30k | 10.6% +₩963.3b | 24.2% | PE39.2x |
